etidronate has been researched along with Hemiplegia in 3 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Hemiplegia: Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study secondary osteoporosis postmenopause in women with hemiplegia and to show the therapeutic effects of etidronate and how osteoporotic conditions relate to the activities of daily living (ADL)." | 5.09 | Prevention of secondary osteoporosis postmenopause in hemiplegia. ( Eun, SS; Hasegawa, C; Ikai, T; Kimura, C; Miyano, S; Uematsu, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, Y | 2 |
| Iwamoto, J | 1 |
| Kanoko, T | 1 |
| Satoh, K | 1 |
| Asoh, T | 1 |
| Kaji, M | 1 |
| Oizumi, K | 1 |
| Ikai, T | 1 |
| Uematsu, M | 1 |
| Eun, SS | 1 |
| Kimura, C | 1 |
| Hasegawa, C | 1 |
| Miyano, S | 1 |
3 trials available for etidronate and Hemiplegia
| Article | Year |
|---|---|
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
Topics: Accidental Falls; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Double-Blind Method | 2005 |
Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.
Topics: Absorptiometry, Photon; Aged; Amino Acids; Bone Density; Bone Diseases, Metabolic; Calcium; Collagen | 2000 |
Prevention of secondary osteoporosis postmenopause in hemiplegia.
Topics: Absorptiometry, Photon; Activities of Daily Living; Aged; Alkaline Phosphatase; Amino Acids; Bone De | 2001 |